GENZ Genzyme Corp. - Genzyme Corp. Common Stock (MM)

CHICAGO, Feb. 11, 2011 /PRNewswire/ -- Zacks.com Analyst Blog features: Laboratory Corporation of America Holdings (NYSE: LH), Genzyme Corporation (Nasdaq: GENZ), Quest Diagnostics (NYSE: DGX), Penn Virginia Resource Partners L.P. (NYSE: PVR) and Cloud Peak Energy Inc. (NYSE: CLD).

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579

Here are highlights from Thursday's Analyst Blog:

LabCorp Beats, Guidance Lowers

Leading lab-testing company Laboratory Corporation of America Holdings (NYSE: LH) reported an EPS of $1.26 in the fourth quarter of fiscal 2010 compared with the year-ago quarter's $1.33. However, after adjusting for restructuring and other special charges, the EPS came in at $1.34, ahead of the Zacks Consensus Estimate of $1.31 and the year-ago quarter's $1.16.

For the full year, the adjusted EPS was $5.55, surpassing the Zacks Consensus Estimate by a penny and $4.89 in the previous year.

Revenues during the quarter increased 11.2% year over year to $1,295.4 million, ahead of the Zacks Consensus Estimate of $1,251 million. Both testing volume (measured by requisitions) and revenue per requisition increased 3.6% and 7.3%, respectively. For 2010, revenues came in at $5003.9 million, up 6.6% and surpassing the Zacks Consensus Estimate of $4,957 million.

While gross margin during the quarter remained unchanged at 40.9%, adjusted operating margin improved by 40 basis points to 19.5%. LabCorp's interest expense increased 31% during the quarter due to higher debt burden.

The company had raised $925 million in November 2010, primarily to fund the acquisition of Genzyme Genetics, a unit of Genzyme Corporation (Nasdaq: GENZ).With the acquisition of Genzyme Genetics, LabCorp expects to strengthen its esoteric testing and personalized medicines business.

LabCorp exited fiscal 2010 with cash and short-term investments of $230.7 million, up 55% compared to $148.5 million at the end of December 2009. In January 2011, the company completed its previous repurchase authorization by purchasing $234.2 million of stock. However, LabCorp has announced another $500 million of buyback program.

Outlook

LabCorp provided its outlook for 2010. The company plans to bring in some changes in its adjusted EPS guidance by excluding intangible amortization associated with acquisitions. The company expects to record adjusted EPS of $5.62-$5.82 (EPS excluding amortization: $6.12-$6.32) on a 9.5%-11.5% revenue growth.

While the Zacks Consensus Earnings Estimate of $5.89 is much higher than the company's guidance, the revenue expectation of $5,506 million is within the range. In addition, operating cash flow and capital expenditure is expected to be $900 million and within $140-$150 million, respectively.

Recommendation

LabCorp continues to focus on strategic initiatives to drive growth and profitability. While companies in the diagnostic space have been witnessing challenges in the form of pricing pressure and lower volume, but situations are not that bad. In this respect, positive volume growth after several quarters recorded by LabCorp's prime competitor, Quest Diagnostics (NYSE: DGX) further ascertains our view.

LabCorp has strong balance sheet based on which the company is looking forward to suitable acquisitions in the esoteric business and expanding its reach. However, the tough competitive landscape is of primary concern, especially in the current economic scenario.

We currently have a Neutral recommendation on the stock, which also corresponds to the Zacks #3 Rank (Hold).

Penn Virginia Dips, Revenues Robust

Penn Virginia Resource Partners L.P. (NYSE: PVR) reported fourth quarter and full-year 2010 results and provided its financial outlook for 2011. Penn Virginia's adjusted fourth-quarter earnings were 26 cents per unit, 5 cents below both the Zacks Consensus estimate of 31 cents and 7 cents below the year-ago earnings of 33 cents.

Penn Virginia's full-year 2010 earnings of 83 cents substantially lagged the Zacks Consensus Estimate of $1.17 but outperformed the year-ago earnings of 76 cents by 9.2%.

Total Revenue

Penn Virginia Resource's total operating revenue of $245.4 million for the fourth quarter of 2010 came in above the Zacks Consensus Estimate of $223 million. Revenue in the quarter also improved 25.9% from $194.9 million reported in the year-ago period, driven by higher revenue contribution from its Natural Gas Midstream and Coal and Natural Resource Management segments.

Full-year 2010 revenue of $864.1 million also outperformed the Zacks Consensus Estimate of $836 million and was 31.6% above last year's revenue of $656.7 million.

Segmental Results

Coal and Natural Resource Management Segment: Revenues at this segment improved 7% year over year to $34.1 million, mainly due to higher coal royalty revenue. The rise in coal royalty revenue in the quarter resulted from a 4.7% increase in coal royalty tons sold and a 2.5% improvement in the price realized per ton sold.

Coal royalty tons sold for the year 2010 totaled 34.5 million (up 0.6%year on year) with coal royalties per ton of $3.78 (up 7.7%), resulting in segment revenue of $138.2 million, an increase of 8.1% year over year. The increase in total coal royalty tons sold combined with overall higher rates per ton led to this rise in revenue.

Natural Gas Midstream Segment: Revenue from this segment in the fourth quarter of 2010 was $204.8 million versus $155.9 million in the year-ago period, implying a growth of 31.4%. System throughput volumes during the quarter increased 31.2% from last year to 36.6 billion cubic feet (Bcf) as a result of additional volumes on the Crossroads and Panhandle systems and new business in the Marcellus shale region.

Full-year segment revenue increased 39% year on year to $702.2 million with system throughput of 129.7 Bcf, which rose 6.9% from the year-ago volumes.

Financial Update

Penn Virginia Resource continues to manage its financial position well, ending the year with $440.4 million remaining under its revolving credit facility and cash and cash equivalents of $10.7 million.

Cash from operating activities for the fourth quarter of 2010 summed $36.9 million, full-year operating cash flow reached $183.7 million. Distributable cash flow (DCF) for the quarter was $44.1 million with full-year DCF totaling $145.8 million.

Penn Virginia Resource spent roughly $96 million for internal growth projects in 2010, out of which $49.5 million was spent in the Marcellus Shale and $28 million for acquisitions in the coal and natural resource segment.

Cash Distribution

The board of directors of the general partner of Penn Virginia Resource has declared a quarterly cash distribution of 47 cents per unit, payable on February 14, 2011, to unit holders of record as on February 7, 2011. The distribution equates to an annualized rate of $1.88 per unit.

Guidance

For 2011, Penn Virginia Resource expects EBITDA to come in at $230 million. Distributable cash flow for the year is expected to be $140 million, net of maintenance and replacement capital of $41 million. The company said the $41 million maintenance and replacement capital will comprise $14 million in maintenance and $27 million of replacement capital for the year.

Penn Virginia Resource expects to invest approximately $140 million in internal growth capital in 2011 including $120 million in the Marcellus Shale.

Our View

Radnor, Pennsylvania-based Penn Virginia Resource manages coal and natural resource properties as well as natural gas gathering and processing businesses. The partnership's coal properties are located in Central and Northern Appalachia, Illinois and San Juan Basins.

Penn Virginia Resources currently has a short-term Zacks #3 Rank (Hold). However, we maintain our long-term Underperform recommendation on the stock. Nevertheless, the partnership stands at par with its closest peer Cloud Peak Energy Inc. (NYSE: CLD), on the basis of short term rank.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5514.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5516

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4580.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Follow us on Twitter:  http://twitter.com/ZacksResearch

Join us on Facebook:  http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

SOURCE Zacks Investment Research, Inc.